A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
Clinical trial NCT05230615 · COMPLETED
Trial details
- NCT number
- NCT05230615
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-01
- Primary completion
- 2023-10-31
- Enrollment
- 458
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.